Difference between revisions of "Part:BBa K2549004"
Line 3: | Line 3: | ||
<partinfo>BBa_K2549004 short</partinfo> | <partinfo>BBa_K2549004 short</partinfo> | ||
− | Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP. | + | Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP[1]. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
Line 12: | Line 12: | ||
<partinfo>BBa_K2549004 SequenceAndFeatures</partinfo> | <partinfo>BBa_K2549004 SequenceAndFeatures</partinfo> | ||
+ | ===References=== | ||
+ | [1]A robust pipeline for rapid production of versatile nanobody repertoires. Fridy PC, Li Y, Keegan S, ..., Chait BT, Rout MP. Nat Methods, 2014 Dec;11(12):1253-60 PMID: 25362362; DOI: 10.1038/nmeth.3170 | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Revision as of 11:31, 6 October 2018
anti-GFP (LaG17)
Anti-GFP(LaG17) is a readily expressible recombinant nanobody which has a relatively low affinity and high specificity against GFP[1]. It can be used as the extracellular domain of the SynNotch, thus accomplishing the contact-dependent signal input against GFP.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 34
References
[1]A robust pipeline for rapid production of versatile nanobody repertoires. Fridy PC, Li Y, Keegan S, ..., Chait BT, Rout MP. Nat Methods, 2014 Dec;11(12):1253-60 PMID: 25362362; DOI: 10.1038/nmeth.3170